SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: tom pope who wrote (905)2/3/2004 12:03:39 AM
From: zeta1961  Read Replies (1) | Respond to of 1005
 
What is the fuss with EYET?

It's bogus, as far as I'm concerned...wait 'til it starts getting used, people hemorrhaging, getting infections...

GENR is somewhat behind, but imo at this point the better one...might pick up a small position in sympathy:)

Regards,
Zeta...



To: tom pope who wrote (905)2/6/2004 1:32:20 PM
From: tuck  Read Replies (2) | Respond to of 1005
 
>>Good idea if you could do it.<<

EYET short . . . How about this? When data shows up on the NASDAQ short interest page, we can assume shares are available for shorting?

nasdaqtrader.com

I just ran it for several of the recent IPOs, and they all have short interest data for January except RNVS and GTXI, which just came out a few days ago.

Cheers, Tuck